COMP <GO>
FLGT vs UNH // OPERATING MARGIN
Fulgent Genetics Inc. (NASDAQ) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: FLGT 2
— UNH 9
▲ OPERATING MARGIN LEADER: UNH
LAST: $19.37 (+0.42%) • MKT CAP: $530.8M
operating-margins
-28.20%
LAST: $404.44 (+1.00%) • MKT CAP: $359.43B
operating-margins
5.32%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (FLGT VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | FLGT | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 40.60% | 88.31% | -47.71 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -6.80% | 12.38% | -19.18 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -20.82% | 6.25% | -27.07 | UNH | /fcf-yield <GO> |
| Operating Margin ACTIVE | -28.20% | 5.32% | -33.52 | UNH | /operating-margins <GO> |
| Net Profit Margin | -18.80% | 3.53% | -22.33 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 13.80% | 3.33% | +10.47 | FLGT | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.29% | -2.29 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.44 | 3.09 | +1.35 | FLGT | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 7/9 | -4.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 7.00% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 40.4 | 55.1 | -14.70 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 17.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $530.8M | $359.43B | -$358.90B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | FLGT REV | UNH REV | FLGT GROSS % | UNH GROSS % | FLGT FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $322.7M | $447.57B | 40.6% | 88.7% | -$124.2M | $16.07B |
| FY 2024 | $283.5M | $400.28B | 37.8% | 88.3% | -$19.3M | $20.70B |
| FY 2023 | $289.2M | $371.62B | — | 89.6% | $27.0M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
FLGT // BETA —
UNH // BETA 0.33